HemaCare Corporation

Dr. Dominic Clarke, Global Head of #CellTherapy, presents at 2:45pm PST today on the "Importance of Donor-Starting Material Characterization in Developing Scalable Cell Therapies". Live panel discussion to follow at 3:20 pm. https://bit.ly/3p9x88M #hemacare #advancingdiscoveries #cellandgenetherapy

Dr. Dominic Clarke, Global Head of Cell Therapy, will be presenting at 2:45 pm PST tomorrow at CHI's Peptalk Virtual Conference & Expo, on the "Importance of Donor-Starting Material Characterization in Developing Scalable Cell Therapies". Live panel discussion to follow at 3:20 pm. https://bit.ly/3o3qcJd

HemaCare and Cellero are joining forces under the umbrella of Charles River Laboratories. The new coalition is a major part of Charles River’s strategy to expand its research and development capacity, by acquiring the expertise needed to bring cellular therapies all the way from sourcing starting materials through to commercialization. https://bit.ly/2XCQffz #hemacare #cellero #advancingdiscoveries #celltherapy

We wish you all a healthy, happy holiday season, and a prosperous new year! In observance of the holidays, HemaCare will be closed on Christmas Day, December 25 and New Year's Day, January 1st. #happyholidays

Read about how COVID-19 associate delays are impacting the quality of cryopreserved CD34+ products. https://bit.ly/31tYWLw #hemacare #advancingdiscoveries #covid19impacts #stemcells

Join us at a free online webinar to learn about the most essential steps and tools to help optimize your cell therapy. HemaCare's Dr. Dominic Clarke is one of the featured presenters. Reserve your seat today >> https://bit.ly/379FHKB #hemacare #advancingdiscoveries #celltherapy #webinaralert

After a study was conducted with patients that had Type II Diabetes and Chronic Kidney Disease, researchers found that patients treated with Linagliptin showed an increase in CD34+ stem cell numbers and migratory function. Learn more about it >> https://bit.ly/37fomjN #hemacare #advancingdiscoveries #stemcells

Johns Hopkins University’s scientists have discovered that breast #cancer cells can change the function in natural killer cells so they prevent metastases. https://bit.ly/3d4uwDV #hemacare #advancingdiscoveries #NKcells #cancerresearch

Work where you know every day you are making a difference in someone’s life; where your strengths, ideas, and expertise will be recognized, appreciated, and rewarded. #NowHiring at HemaCare, a Charles River Company. Visit our Careers page to see available #employment opportunities and to apply: https://bit.ly/33kZHrw #research #manager #laboratory #production #jobs #jobopening #jobsearch #careers #HR #career

Read about a groundbreaking cancer detection study published in "Cell" citing the use of HemaCare-sourced human #bonemarrow >>> https://bit.ly/2GhNaw2 #hemacare #advancingdiscoveries #cancerresearch

Researchers have found that T Cells can target cells that are in a state of cellular senescence, without damaging the tissues while promoting a longer life span. Read all about it here >> https://bit.ly/3mMhq2y #hemacare #advancingdiscoveries #cart #tcells

Researchers at the University of California San Diego used #NKcells in a study as immunotherapeutic agents. They found that the natural killer cells are effective in ridding tumor cells from the body. Read about it here >> https://bit.ly/2RCdqUc #hemacare #advancingdiscoveries

Our latest blog highlights clinical trials conducted by The University of Oxford on a possible vaccine for SARS-CoV-2 and how the results produced a positive immune response. Read all about it here >> https://bit.ly/3k2FSus #hemacare #advancingdiscoveries #tcells #vaccineresearch

Download NEW white paper here >>> https://bit.ly/2Zl2oXR Mr. Darren Pelio, MHS, PA, HemaCare’s Bone Marrow Aspiration Specialist, and one of the industry’s most experienced hematology-oncology experts, brings to light the complexity of #bonemarrow aspiration and why technical expertise is critical for obtaining the highest possible product quality while also ensuring donor safety and comfort. #hemacare #advancingdiscoveries

Scientists are learning something new about Coronavirus every day. Now they learn that those who were infected, but tested negative for COVID-19 antibodies, developed #Tcells instead, in a response to their COVID-19 infections. Read more about it in our latest blog >> https://bit.ly/3gQ2Pzc #hemacare #advancingdiscoveries #vaccineresearch

Our latest blog highlights a recent collaborative study published by Amgen and Kite Pharma. They cite the use of HemaCare-sourced #PBMCs in their investigative effort on the development of a novel #CART #celltherapy. https://bit.ly/2YwkxkO #hemacare #advancingdiscoveries

Pleased to participate today and tomorrow in the program of The 12th Annual Bioprocessing Summit (#BPSMT) Virtual Meeting. Dr. Dominic Clarke, Global Head of Cell Therapy at HemaCare and ISCT Process & Product Committee Co-Chair, will be chairing and moderating three cell therapy sessions: >> Tuesday, August 25, 2020 | 11:45 AM 1:05 PM EST ISCT SESSION: ADVANCING PRODUCT DEVELOPMENT... >> Tuesday, August 25, 2020 | 1:40 PM 3:00 PM EST ISCT SESSION: STAGING FOR COMMERCIAL SUCCESS >> Wednesday, August 26, 2020 | 1:50 PM 3:05 PM EST PLENARY KEYNOTE SESSION: LEADING TO TOMORROW’S ADVANCES For further information about the Summit, visit: https://bit.ly/2YAdlnI #hemacare #advancingdiscoveries #celltherapy